Ultragenyx, NephroGenex set IPO terms

Orphan drug company Ultragenyx Pharmaceutical Inc. (Novato, Calif.) and kidney disease company NephroGenex Inc. (Research Triangle Park, N.C.) set IPO terms late

Read the full 227 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE